STOCK TITAN

OneMedNet Announces Continued Investment into Bitcoin

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

OneMedNet (Nasdaq: ONMD), a pioneer in curating regulatory-grade Real World Data (RWD), has announced an additional strategic investment in Bitcoin. As of November 12, 2024, the company has acquired approximately 34 Bitcoin. The investment aims to enhance financial resilience and support the expansion of their iRWD™ platform. Off The Chain Capital, a significant investor in OneMedNet, has provided expertise regarding Bitcoin investments. The company's Bitcoin strategy follows the approach pioneered by Michael Saylor and MicroStrategy.

OneMedNet (Nasdaq: ONMD), un pioniere nella curazione di dati del mondo reale di grado regolatorio (RWD), ha annunciato un ulteriore investimento strategico in Bitcoin. A partire dal 12 novembre 2024, l'azienda ha acquisito circa 34 Bitcoin. L'investimento mira a migliorare la resilienza finanziaria e a supportare l'espansione della loro piattaforma iRWD™. Off The Chain Capital, un investitore significativo in OneMedNet, ha fornito competenze riguardo agli investimenti in Bitcoin. La strategia aziendale relativa ai Bitcoin segue l'approccio pionieristico di Michael Saylor e MicroStrategy.

OneMedNet (Nasdaq: ONMD), un pionero en la curación de datos del mundo real de calidad regulatoria (RWD), ha anunciado una inversión estratégica adicional en Bitcoin. A partir del 12 de noviembre de 2024, la empresa ha adquirido aproximadamente 34 Bitcoin. La inversión tiene como objetivo mejorar la resiliencia financiera y apoyar la expansión de su plataforma iRWD™. Off The Chain Capital, un importante inversor en OneMedNet, ha proporcionado experiencia en inversiones en Bitcoin. La estrategia de Bitcoin de la compañía sigue el enfoque pionero de Michael Saylor y MicroStrategy.

OneMedNet (Nasdaq: ONMD)는 규제 기준의 실제 데이터(RWD)를 정리하는 선구자로서 비트코인에 대한 추가 전략 투자 발표했다. 2024년 11월 12일 기준으로, 이 회사는 약 34개의 비트코인을 인수했다. 이 투자의 목표는 재정적 회복력을 강화하고 iRWD™ 플랫폼의 확장을 지원하는 것이다. OneMedNet의 주요 투자자인 Off The Chain Capital은 비트코인 투자에 대한 전문 지식을 제공했다. 회사의 비트코인 전략은 Michael Saylor와 MicroStrategy가 개척한 접근 방식을 따른다.

OneMedNet (Nasdaq: ONMD), un pionnier dans la curation de données du monde réel de qualité réglementaire (RWD), a annoncé un nouvel investissement stratégique dans le Bitcoin. À partir du 12 novembre 2024, l'entreprise a acquis environ 34 Bitcoins. Cet investissement vise à renforcer la résilience financière et à soutenir l'expansion de leur plateforme iRWD™. Off The Chain Capital, un investisseur important dans OneMedNet, a apporté son expertise sur les investissements en Bitcoin. La stratégie de l'entreprise en matière de Bitcoin suit l'approche pionnière de Michael Saylor et MicroStrategy.

OneMedNet (Nasdaq: ONMD), ein Pionier in der Kurierung von regulierungsfähigen Real-World-Daten (RWD), hat eine weitere strategische Investition in Bitcoin angekündigt. Am 12. November 2024 hat das Unternehmen ungefähr 34 Bitcoin erworben. Die Investition zielt darauf ab, die finanzielle Widerstandsfähigkeit zu verbessern und die Erweiterung ihrer iRWD™-Plattform zu unterstützen. Off The Chain Capital, ein wichtiger Investor bei OneMedNet, hat Fachkenntnisse in Bezug auf Bitcoin-Investitionen bereitgestellt. Die Bitcoin-Strategie des Unternehmens folgt dem Ansatz, den Michael Saylor und MicroStrategy vorangetrieben haben.

Positive
  • Strategic investment in 34 Bitcoin to potentially preserve treasury value
  • Backing from experienced crypto investor Off The Chain Capital
Negative
  • Exposure to volatile cryptocurrency market risks
  • Allocation of company resources to speculative assets instead of core business operations

Insights

The investment in 34 Bitcoin by OneMedNet represents a significant and risky treasury management decision for a micro-cap company valued at just $20 million. This follows MicroStrategy's controversial playbook but at a much smaller scale. At current Bitcoin prices, this investment likely represents a substantial portion of OneMedNet's cash reserves, which could impact operational flexibility and increase volatility risk.

While Bitcoin investment may serve as an inflation hedge, the high volatility of cryptocurrency makes this a particularly aggressive strategy for a small healthcare technology company. The move signals a significant pivot from traditional corporate treasury management to a more speculative approach. Investors should carefully evaluate whether such a strategy aligns with the company's core business model and risk profile.

OneMedNet's Bitcoin investment appears disconnected from its core business of healthcare data management and the iRWD™ platform. While cryptocurrency adoption by corporations is growing, there's no clear strategic synergy between Bitcoin holdings and the company's primary mission of curating regulatory-grade Real World Data. This diversion of resources from core operations and R&D could potentially slow down essential platform developments and market expansion in their primary business area.

MINNEAPOLIS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a pioneer in curating regulatory-grade Real World Data (RWD) including electronic health records, laboratory results, and medical imaging, has announced an additional strategic investment in Bitcoin. This investment is designed to enhance the company's financial resilience and support the expansion of its cutting-edge iRWD™ platform. As of November 12, 2024, the Company has invested in approximately 34 Bitcoin.

Off The Chain Capital has made significant investments in OneMedNet through multiple funding rounds, and their expertise regarding Bitcoin has been invaluable. Brian Estes, Chief Investment Officer, of Off The Chain Capital, shared, “We believe Bitcoin will become the monetary layer of the world over the next few decades, much like gold was for over 3000 years. Companies that embrace this vision will gain a strategic advantage over those losing the purchasing power of their treasury reserves due to the debasement of fiat currencies.”

OneMedNet has adopted a Bitcoin on the balance sheet strategy based on the approach Michael Saylor and MicroStrategy (MSTR) pioneered, which reflects a forward-looking approach to corporate treasury management that incorporates digital currencies.

This investment is part of OneMedNet's commitment to sustainable growth and innovation that supports the healthcare community through high-quality, compliant regulatory grade clinical data. The iRWD™ platform provides secure, comprehensive management of diverse de-identified clinical data, from electronic health records and laboratory results to medical imaging, across our network of 1,400+ healthcare partner sites playing a crucial role in advancing medical research, improving patient care, and driving healthcare innovation.

Aaron Green, CEO and President of OneMedNet, stated, “By continuing to invest a portion of our assets into Bitcoin, we aim to not only safeguard our financial stability but also fuel the ongoing development and innovation within our iRWD™ platform. This move positions OneMedNet at the intersection of healthcare, technology, and finance, setting a precedent for how healthcare data companies can leverage modern financial assets to enhance operational capabilities and contribute to broader advancements in healthcare technology."

For more information about OneMedNet and its iRWD™ platform, please visit www.onemednet.com

About OneMedNet Corporation

OneMedNet provides innovative solutions that unlock the significant value contained within the Real-World Data (“RWD”) repositories of over 1,400 healthcare system and provider sites that currently comprise its iRWD™ network. OneMedNet’s proprietary iRWD™ platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results, and uniquely, medical imaging. Employing its robust iRWD™ platform, the Company securely de-identifies, searches, and curates the clinical data, bringing a wealth of internal and third-party research opportunities to its drug, medical device and imaging/diagnostic AI development customers.

OneMedNet’s platform is designed to meet the clinical requirements necessary across various domains, including but not limited to rare diseases, oncology and cardiology. The Company is committed to delivering precise and robust research support services that span the entire continuum of care. This commitment is a cornerstone of OneMedNet’s strategy to enhance patient outcomes and help pave the next wave of healthcare innovation. For more information, please visit www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timeline for the Company to regain compliance with the listing rules of The Nasdaq Stock Market LLC relating to the timely filing of periodic reports with the SEC; risks inherent with investing in Bitcoin, including Bitcoin's volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

OneMedNet Contacts:

Michael Wong, Director of Marketing
Phone: 800.918.7189
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION


FAQ

How many Bitcoin does OneMedNet (ONMD) own as of November 2024?

As of November 12, 2024, OneMedNet (ONMD) owns approximately 34 Bitcoin.

What is the purpose of OneMedNet's (ONMD) Bitcoin investment?

OneMedNet's Bitcoin investment is designed to enhance the company's financial resilience and support the expansion of its iRWD™ platform.

Which investment strategy is OneMedNet (ONMD) following for its Bitcoin investments?

OneMedNet is following the Bitcoin balance sheet strategy pioneered by Michael Saylor and MicroStrategy (MSTR).

OneMedNet Corp

NASDAQ:ONMD

ONMD Rankings

ONMD Latest News

ONMD Stock Data

32.19M
11.29M
59.65%
21.53%
0.99%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States of America
SURREY